SUU, Alm.del - 2009-10 - Endeligt svar på spørgsmål 288: Spm. om at sende udvalget kopi af al korrespondance, som ministeriet, herunder Sundhedsstyrelsen har haft med tyske sundhedsmyndigheder samt Prof. Vogels afdeling i Frankfurt, til ministeren for sundhed og forebyggelse

Dear Professor, DMSc Thomas J. VoglBeing a small country, Denmark has profound interest in international col-laboration and exchange of experience within the health services. The Dan-ish Health Care System is constantly looking for possible innovations in or-der to ensure development and introduction of new treatment modalities asearly as possible. At the same time it is very important for us that scientificevidence is collected systematically so that evidence based guidelines can bemade and evidence based decisions taken regarding diagnoses, treatment,and care.During the last years, an increasing number of Danish patients with hepaticmetastases from various types of cancers have travelled to your clinic to re-ceive treatment.In order to advise patients the best possible way, the Danish National Boardof Health needs documented scientific evidence on the treatment in question.Therefore, the Danish National Board of Health has decided to obtain moredetailed knowledge about the treatment you offer to Danish patients bothwith respect to efficacy and safety.The Danish National Board of Health therefore by this letter kindly requestsyou to submit information on the following issues:

1. Could you please state your criteria for inclusion of patients for in-trahepatic chemotherapy, especially regarding patients with extra-hepatic metastases as well.2. On which criteria are the cancer drugs for intrahepatic chemotherapychosen for the various types of cancer?3. Are the results of intrahepatic chemotherapy collected according to aparticular scientific protocol ensuring a systematic collection of sci-entific evidence?

4. Are Danish patients offered intrahepatic chemotherapy as part of ascientific protocol?5. Do you have any scientific evidence from randomized trials indicat-ing that intrahepatic chemotherapy of hepatic metastases for each ofthe cancer types in question offers advantages to patients as com-pared to systemic exposure with chemotherapy?The information from you would be of importance for the Danish NationalBoard of Health and the Danish Health System in general in order to satis-factorily assist and advise Danish cancer patients who may wish to considerreceiving treatment abroad.Looking forward to your reply, and thanking you in advance for your kindcooperation.Yours sincerely,

7 July 2009

Health Planning

National Board of Health

Islands Brygge 67

DK- 2300 København S

Phone +45 72 22 74 00

Fax

+45 72 22 74 05

E-mail [email protected]

Dir. ph. +45 7222 7647

E-mail [email protected]

National Board of Health